Medicine for treating primary sicca syndrome and preparation method thereof

A technology for Sjögren's syndrome and primary disease, which is applied in the direction of drug combinations, pharmaceutical formulas, and medical preparations containing active ingredients, etc. It can solve problems such as treatment limitations, limited effects, and large toxic and side effects of drugs, and achieve clear curative effects.

Inactive Publication Date: 2019-10-15
李雯燕
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because the etiology and pathogenesis of pSS are not very clear, the drugs currently used have very limited effects, including the improvement of symptoms and the delay of the disease.
[0007] (2) Existing drugs have large toxic and side effects
[0008] Difficulty in solving the above technical problems: because the pathogenesis of the disease has not been elucidated, the treatment is very limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating primary sicca syndrome and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0036] Such as figure 1 As shown, the preparation method of the medicine for the treatment of primary Sjogren's syndrome provided by the embodiments of the present invention comprises the following steps:

[0037] S101: Preparation of raw materials, including: Atractylodes macrocephala, yam, kudzu root, platycodon, angelica, rehmannia glutinosa, black plum, white peony root, ginseng, ginseng, asparagus, ophiopogon, dendrobium, habitat, mint and mulberry leaves;

[0038] S102: First cleaning: according to the characteristics of each raw material, use special cleaning tools to clean each raw material for the first time;

[0039] S103: the second cleaning: sterilize each raw material with alcohol, and then perform a second cleaning with sterile water to clean the alcohol;

[0040] S104: drying: Atractylodes macrocephala, yam, kudzu root, bellflower, angelica, rehmannia glutinosa, ebony plum, white peony root, Nansha ginseng, northern radix ginseng, asparagus, Ophiopogon japonicus,...

Embodiment 1

[0048] The medicine for the treatment of primary Sjögren's syndrome provided by the embodiment of the present invention consists of 30g of Atractylodes macrocephala, 50g of Chinese yam, 15g of kudzu root, 10g of bellflower, 10g of angelica, 15g of rehmannia glutinosa, 30g of black plum, 24g of white peony root, 23g of Nansha ginseng, and 30g of Beisha ginseng. , asparagus 12g, Ophiopogon japonicus 17g, dendrobium 30g, habitat 30g, mint 5g and mulberry leaves 13g.

[0049] The preparation method of the medicine for treating primary Sjögren's syndrome provided by the embodiments of the present invention comprises the following steps:

[0050] The first step is the preparation of raw materials, including: Atractylodes macrocephala, yam, kudzu root, platycodon, angelica, rehmannia, black plum, white peony, Nansha, Beisha, asparagus, Ophiopogon japonicus, dendrobium, habitat, mint and mulberry leaves;

[0051] The second step, the first cleaning: according to the characteristics of...

Embodiment 2

[0058] The medicine for the treatment of primary Sjögren's syndrome provided by the embodiment of the present invention consists of 30g of Atractylodes macrocephala, 50g of Chinese yam, 15g of pueraria lobata, 10g of bellflower, 10g of angelica, 30g of Rehmannia glutinosa, 15g of black plum, 26g of white peony root, 18g of Nansha ginseng, and 25g of Beisha ginseng. , asparagus 10, Ophiopogon japonicus 15g, dendrobium 22g, habitat 30g, mint 3 and mulberry leaves 11g.

[0059] The preparation method of the medicine for treating primary Sjögren's syndrome provided by the embodiments of the present invention comprises the following steps:

[0060] The first step is the preparation of raw materials, including: Atractylodes macrocephala, yam, kudzu root, platycodon, angelica, rehmannia, black plum, white peony, Nansha, Beisha, asparagus, Ophiopogon japonicus, dendrobium, habitat, mint and mulberry leaves;

[0061] The second step, the first cleaning: according to the characteristics...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine for treating primary sicca syndrome and a preparation method thereof. The medicine consists of 30g of bighead atractylodes rhizome, 50g of rhizoma dioscoreae, 15g ofradix puerariae, 10g of radix platycodonis, 10g of radix angelicae sinensis, 15-30g of radix rehmanniae preparata, 15-30g of fructus mume, 20-30g of radix paeoniae alba, 15-30g of adenophora tetraphylla, 15-30g of radix glehniae, 10-20g of radix asparagi, 10-20g of radix ophiopogonis, 20-30g of herba dendrobii, 30g of rehmannia roots, 3-6g of mint and 10-15g of mulberry leaves. According to the invention, the technique is applied to clinically-diagnosed patients with primary sicca syndrome in Hami region by combining years of clinical traditional Chinese and western medicine combined diagnosis and treatment experience. The medicine has the advantages that the medicine actively explores advantages of traditional Chinese medicine for treating difficult diseases, makes up western medicine treatment limitation, and has very important popularization value and practical significance.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations containing undetermined structures from algae, moss, fungus or plants or derivatives thereof, such as traditional herbal medicines, and particularly relates to a medicine for treating primary Sjogren's syndrome and a preparation method thereof. Background technique [0002] Currently, the closest prior art: primary Sjogren's syndrome (primary Syndrome (pSS) is a chronic autoimmune disease mainly involving exocrine glands. The main clinical manifestation is dry mouth and eyes caused by damage to salivary glands and lacrimal glands. Multiple system damages such as lungs, liver, kidneys, blood system, and nervous system may also occur. . Exocrine gland injury disease caused by immune dysfunction is characterized by dry mouth and eyes clinically, and high lymphocyte infiltration in exocrine gland pathologically. [0003] The clinical manifestations of pSS are complex and diverse...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8984A61P37/02A61P1/02A61P27/02
CPCA61K36/23A61K36/232A61K36/284A61K36/342A61K36/346A61K36/488A61K36/534A61K36/605A61K36/65A61K36/71A61K36/736A61K36/804A61K36/8945A61K36/8965A61K36/8968A61K36/8984A61K2236/13A61K2236/17A61K2236/331A61K2236/51A61P1/02A61P27/02A61P37/02A61K2300/00
Inventor 李雯燕王文静刘佳张成强赵振新周生潮闫琛郭洪涛宋国平
Owner 李雯燕
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap